Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

at the heart of Singapore's life sciences hub. Tuas is home to upwards of 14 companies employing around 7,000 employees, with Amgen, GSK, Pfizer, AbbVie, MSD, Novartis, and Roche among Sanofi's ...

with Amgen, GSK, Pfizer, Sanofi, MSD, Novartis, and Roche among AbbVie’s neighbours. “We are grateful for AbbVie’s continued trust in the strength of Singapore’s biopharmaceutical ...

Hotel101 Global Pte. Ltd ("Hotel101" or "HBNB"), an asset-light, prop-tech hospitality platform business designed for rapid global growth, and JVSPAC Acquisition Corp. ("JVSPAC"), a special purpose ...

Free cash flow surged to $4.4 billion, up a remarkable 1,367% year over year. Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.

NEW YORK (Reuters) - Bank of America expects record net interest income in 2025, the head of its retail banking unit said on ...

MariTide Phase 3 studies to begin in first half of year FDA places hold on AMG 513 obesity drug trial Amgen's Q4 earnings beat estimates, revenue up 11% Feb 4 (Reuters) - Amgen (AMGN.O), opens new ...

Amgen is a biotechnology leader with competitive advantages in scale, R&D, manufacturing efficiency, and distribution, bolstered by a robust pipeline and rising margins. I currently rate Amgen as ...

Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS ...